US Measles-Free Status at Risk
Analysis based on 6 articles · First reported Jan 20, 2026 · Last updated Jan 21, 2026
The potential loss of measles-free status for the United States and Mexico could lead to increased healthcare expenditures for managing outbreaks and a decline in public trust in health institutions. Pharmaceutical companies involved in vaccine production may see increased demand, while industries reliant on international travel could face disruptions due to health advisories.
International health authorities are set to meet in April to determine if the United States has lost its measles-free designation, a year after an outbreak began in West Texas. The United States — Centers for Disease Control and Prevention confirmed 2,144 measles cases across 44 states in 2025, the most since 1991. Experts attribute the resurgence to declining vaccination rates, parental waivers, healthcare access issues, and misinformation, including doubts sown by Trump administration health officials. The World Health Organization will make the final decision, also reviewing Mexico's measles-free status, which has a significant outbreak linked to Texas. The situation highlights a broader measles problem across North America, with concerns about continuous transmission and the financial burden of contact tracing and outbreak management.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard